| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/25/2003 | US20030180902 Method and apparatus for selectively targeting specific cells within a mixed cell population |
| 09/25/2003 | US20030180888 CD2000 and CD2001 molecules, and uses thereof |
| 09/25/2003 | US20030180887 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/25/2003 | US20030180883 Human tumor necrosis factor receptor TR10 |
| 09/25/2003 | US20030180881 PRO polypeptides; fusion proteins; immunoglobulins |
| 09/25/2003 | US20030180879 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180878 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180877 Gene therapy; drug screening |
| 09/25/2003 | US20030180876 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180875 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180874 PRO polypeptides; fusion proteins; immunoglobulins; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by skeletal cells; for stimulating release of proteoglycans from cartilage |
| 09/25/2003 | US20030180873 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180872 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180871 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by adipocyte cells; for release of proteoglycans from cartilage |
| 09/25/2003 | US20030180870 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by adipocyte cells; for release of proteoglycans from cartilage |
| 09/25/2003 | US20030180869 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180868 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180866 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by skeletal cells/adipocytes; for stimulating the release of proteoglycans from cartilage |
| 09/25/2003 | US20030180865 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180864 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180863 PRO polypeptides; fusion proteins |
| 09/25/2003 | US20030180862 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180861 PRO polypeptides; fusion proteins |
| 09/25/2003 | US20030180860 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180859 PRO polypeptides; fusion proteins |
| 09/25/2003 | US20030180858 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180857 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180856 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180855 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180854 PRO polypeptides; fusion proteins |
| 09/25/2003 | US20030180853 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180852 PRO polypeptides; fusion proteins |
| 09/25/2003 | US20030180851 PRO polypeptides; fusion proteins |
| 09/25/2003 | US20030180850 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180849 PRO polypeptides; fusion proteins |
| 09/25/2003 | US20030180848 PRO polypeptides; fusion proteins; immunoglobulins |
| 09/25/2003 | US20030180847 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180846 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180845 A nucleic acid sequence encoding the extracellular domain of the polypeptide, lacking its associated signal peptide |
| 09/25/2003 | US20030180844 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180843 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180842 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180841 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180840 A nucleic acid sequence encoding the extracellular domain of the polypeptide, lacking its associated signal peptide |
| 09/25/2003 | US20030180839 A nucleic acid sequence encoding the extracellular domain of the polypeptide, lacking its associated signal peptide |
| 09/25/2003 | US20030180838 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180837 A nucleic acid sequence encoding the extracellular domain of the polypeptide, lacking its associated signal peptide |
| 09/25/2003 | US20030180836 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180825 Analyte measurement device and method of use |
| 09/25/2003 | US20030180824 System for performing blood coagulation assays and measuring blood clotting times |
| 09/25/2003 | US20030180823 Use of metabolic phenotyping |
| 09/25/2003 | US20030180822 Detection of erythropoietin and erythropoietin receptor |
| 09/25/2003 | US20030180821 Identifying an agent that bind gene products critical for the survival of microbes, such as staphylococcus microbe, and that interfere with the expression of such gene products |
| 09/25/2003 | US20030180820 Tests for the rapid evaluation of ischemic states and kits |
| 09/25/2003 | US20030180819 Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples |
| 09/25/2003 | US20030180818 Isolated nucleic acid molecules encoding human peptidoglycan recognition protein-related proteins, referred to PGRP-K (keratinocytes), PGRP-W (wound healing) and PGRP-C (chondrosarcoma) |
| 09/25/2003 | US20030180817 Determining levels of a colon specific gene in the cells, or bodily fluids in a patient, comparing determined levels of CSG with levels of CSG in cells from normal human control, wherein a change in level of CSG indicates presence of cancer |
| 09/25/2003 | US20030180815 Enzyme substrate and/or wash delivery in one step immunoassays |
| 09/25/2003 | US20030180814 Direct immunosensor assay |
| 09/25/2003 | US20030180811 Immunoassays for beta2-microglobulin |
| 09/25/2003 | US20030180809 Kits for cholesterol analysis comprising antibodies reactive with lipoproteins, for measuring absorbance |
| 09/25/2003 | US20030180808 Drug signatures |
| 09/25/2003 | US20030180806 Method of assay by immunoreaction and reagent for use in the immunoreaction assay |
| 09/25/2003 | US20030180804 (Serine) protease modulators; membrane proteins |
| 09/25/2003 | US20030180803 Lead molecule generation |
| 09/25/2003 | US20030180802 Nematode fatty acid desaturase-like sequences |
| 09/25/2003 | US20030180800 Analyzing non-toxic stable labeled glucose isotope formation via mass spectrometry/nuclear magnetic resonance |
| 09/25/2003 | US20030180799 Antibodies against plasma cells |
| 09/25/2003 | US20030180798 Analyzing second messenger sigalling activity; drug screening |
| 09/25/2003 | US20030180797 Identification of ligands for a receptor family and related methods |
| 09/25/2003 | US20030180796 Fibroblast/epidermal growth factors; PRO polypeptides |
| 09/25/2003 | US20030180795 Monoclonal/humanized antibodies; fusion proteins; PRO polypeptides |
| 09/25/2003 | US20030180794 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180793 Monoclonal/humanized antibodies; fusion proteins; PRO polypeptides |
| 09/25/2003 | US20030180792 Fusion proteins; PRO polypeptides; fibroblast/nerve growth factor receptors |
| 09/25/2003 | US20030180786 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/25/2003 | US20030180780 3-aminopropyltrimethoxysilane-coated metal oxides for use as labelling reagents in DNA analysis |
| 09/25/2003 | US20030180778 UDP-N-acetylglucosamine: galactose-beta1,3-N-acetylgalactosamine-alpha-R/ (GlcNAc to GalNAc) beta1,6-N-acetylglucosaminyltransferase, C2GnT3 |
| 09/25/2003 | US20030180772 Detection of DNA damage |
| 09/25/2003 | US20030180771 Electrochemically analyzing samples from selected areas of the body of living organism for elevated free levels of nucleotide excision products resulting from DNA or RNA damage |
| 09/25/2003 | US20030180770 Novel compositions and methods for the identification, assessment, prevention and therapy of ovarian cancer |
| 09/25/2003 | US20030180764 Genes affected by cholesterol treatment and during adipogenesis |
| 09/25/2003 | US20030180762 Mild enrichment of foetal cells from peripheral blood and use thereof |
| 09/25/2003 | US20030180759 Antigen derived from the gp160 env precursor protein (glycoprotein120 envelop protein)of a HIV-1 group O strain contains an amino acid sequence characterized by the fact that it reacts with antibodies raised against such antigen |
| 09/25/2003 | US20030180758 Co-amplifying a set of at least three microsatellite loci of genomic DNA, containing one mononucleotide repeat locus and atleast two tetranucleotide repeat loci, from the sample of genomic DNA in a multiplex amplification reaction |
| 09/25/2003 | US20030180750 Treatment of cancer and neurological diseases |
| 09/25/2003 | US20030180749 Methods for generating databases and databases for identifying polymorphic genetic markers |
| 09/25/2003 | US20030180748 Splitting nucleic acid sample into separate reaction vessels; contacting one vessel nucleic acid with bisulfite, amplifying and cleaving both nucleic acids to produce fragments, obtaining mass spectra of both to detect cytosine methylation |
| 09/25/2003 | US20030180744 High affinity oligonucleotide ligands to growth factors |
| 09/25/2003 | US20030180743 Method of examining allergic diseases |
| 09/25/2003 | US20030180742 A polypetide; catalyzes the hydrolysis of epoxides and arene oxides to their corresponding diols |
| 09/25/2003 | US20030180740 Identifying a genetic element whose expression differs, when gene expression in first and/or second cell is compared under at least two different environmental conditins relevant ot the cellular proecess |
| 09/25/2003 | US20030180739 Culturing a cell in the presence or absence of the compound, assaying the cell for expression or activity of gene(s), detecting the compound when expression of the genes is lower in the presence of the compound than in the absence |
| 09/25/2003 | US20030180736 Methods for the early diagnosis of ovarian cancer |
| 09/25/2003 | US20030180721 Detecting the presence of cytomegalovirus (CMV) in a fetal sample by determining the presence of anti-hsp70 (heat shock proteins) antibodies present in the fetal sample |
| 09/25/2003 | US20030180720 Analyte-shaped cavities associated with enhancing particle structures for analyte detection |
| 09/25/2003 | US20030180719 Human cellular protein gastrointestinal glutathione peroxidase as target for medical intervention against hepatitis C virus infections |
| 09/25/2003 | US20030180718 Target specific screening and its use for identifying target binders |
| 09/25/2003 | US20030180716 Microbe indentifying method, microbe identifying apparatus, method for creating database for microbe identification, microbe identifying program, and recording medium on which the same is recorded |
| 09/25/2003 | US20030180715 Methods and means for assessing HIV envelope inhibitor therapy |